Stay updated on XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Sign up to get notified when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site revision was updated from v3.6.3 to v3.6.4, indicating a new build deployment. The study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-07-25T18:34:30.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.2 to v3.6.3, signaling a small maintenance update to the site.
    Difference
    0.1%
    Check dated 2026-07-04T05:25:02.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.6.2 was added and Revision: v3.6.0 was removed, indicating a software update to the page. This change does not affect the study details, eligibility criteria, or any content about the clinical trial.
    Difference
    0.1%
    Check dated 2026-06-27T03:25:08.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate enrollment is closed, and new user-guidance sections were added to help users understand the study record and how to join. A label formatting change for Intervention/Treatment and a revision tag update were also applied.
    Difference
    0.5%
    Check dated 2026-06-12T23:36:10.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The page revision in the footer was updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This reflects a metadata update rather than a change to the visible content.
    Difference
    0.1%
    Check dated 2026-06-05T17:50:01.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Removed the Related Topics entries (including Prostate cancer and MedlinePlus Genetics) from the study page. This reduces the related resources displayed alongside the study details, affecting navigational context for users exploring related topics.
    Difference
    0.2%
    Check dated 2026-05-22T11:53:20.000Z thumbnail image

Stay in the know with updates to XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.